Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$53.35 -0.01 (-0.02%)
2/9/2010 4:01 PM

Abbott Laboratories (ABT)

CAPS Rating:
*****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ABT

Add Stock to Watchlist

What the Community Thinks

Total Members

1625 Outperforms
78 Underperforms
 

All-Stars

533 Outperforms
14 Underperforms
 

Wall Street

26 Outperforms
0 Underperforms
 

Members bullish on ABT are also bullish on:

Members bearish on ABT are also bearish on:

Ticker Tags

Medical Device (40), Pharmaceuticals (149), Healthcare (711), Growth (1902), Mega Cap (110), Chicago (30), Blue Chip (106), Illinois (18), S&P 500 (499), Dividend (191), Defensive (1457), Multinational Company (15), Big Pharma (10)
Suggest a tag

Abbott Laboratories At A Glance

Current Price: $53.35
Last Trade Time: 2/9/2010 4:01 PM
Open: $53.64
Previous Close: $53.35
Daily Range: $53.34 - $53.98
52-Week Range: $41.27 - $57.36
Volume: 11,145,416
Market Cap: $82.52B
P/E Ratio: 14.34
Compare Our Special Broker Offers!

Stock Trends

ABT VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ABT

More Headlines...

Top Bull Pitch

Recs

15

Abbott Laboratories (ABT)

Avatar TheGolden13 (97.12) Submitted: 11/27/09 1:11 PM

Even though I would rather see a company reinvest dividends because if I am investing in them I have to believe they can make more money with the dividend than I can. Having said that, Abbot has had increasing dividends for over 10 years. This shows strength in the midst of one recession and Depre...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Abbott Laboratories (ABT)

Avatar boiseidfool (89.97) Submitted: 3/03/07 9:35 AM

Idaho has filed a lawsuit that alleges Abbott Laboratories falsified wholesale drug prices and that the state has overpaid Medicaid reimbursements because of the manipulated drug prices. In the complaint, the Idaho attorney general's office says the prices charged to hospitals and pharmacies for Ab...More

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 226 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ABT)

Avatar baselineace (< 20) Submitted: 2/04/10 8:22 AM : Outperform Start Price: $54.75 ABT Score: -0.94

Heebner + Goldman Sachs, 5-star Morningstar rating, 5-star CAPS rating

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar dcooper101 (74.35) Submitted: 2/02/10 11:22 PM : Outperform Start Price: $54.37 ABT Score: 0.54

Defensive pick. I actually think earnings will be just about even or bit below the S&P 500 avg. However, Abbott is a stalwart amongst stable dividend paying blue-chips and and the above avg (in comparison to the index), yet sustainable yield makes this a low-risk proposition for moderate out-performance.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar SUPERMANSTOCKS (27.04) Submitted: 1/25/10 9:05 PM : Underperform Start Price: $54.65 ABT Score: 0.34

This is a great drug company! Pays an excellent dividend quarterly ( # Div/yield 0.40/2.93 ) Right now this is under performing. However, by the end of year you will see good numbers for this company. So long as the Obama healthcare plan dies!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar SgtGlenn (26.41) Submitted: 1/25/10 3:07 PM : Outperform Start Price: $54.79 ABT Score: 0.15

I have owned and will own this stock again. Very conservative play. Low debt, high cash, excellent management, and a legally protected core business (drug patents).

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar mrindependent (99.29) Submitted: 1/20/10 7:57 PM : Outperform Start Price: $56.21 ABT Score: 0.79

Abbott Laboratories is a good play on the concept that the health care reforms will not be as devastating as feared for health care providers. This company currently qualifies for my Stable Dividends screen which requires a sustainable dividend in excess of 2%, a low payout ratio, reasonable debt/equity, high interest coverage ratio and solid earnings. Since January1, 2000, this screen has outperformed the S&P 500 by 16.6% per year on average. Earnings trends look solid for Abbott Laboratories, but the company is undervalued in relation to its historical norms. Current p/bv is 4.01. Five year median p/bv is 4.62. Current p/sales is 2.87. Five year median is 3.08. CAPS 5, Stockscouter 7.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 226 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 26 of 26  

picks per page. CHANGE Expand All Pitches

Top
Pick		Member NameMember RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackGoldmanSach < 20 01/21/10 Outperform 5Y $56.21-5.09%-5.88%+0.79 Toggle the visibility of 60-Second Pitch and replies
TrackWedbush 66.12 11/12/09 Outperform NS $53.00+0.65%-2.53%+3.18
TrackHilliard 76.32 08/13/09 Outperform NS $43.50+22.64%+6.49%+16.15
TrackTobinSmith < 20 05/15/09 Outperform 1Y $42.29+26.16%+22.13%+4.02
TrackBarclaysCap 94.50 04/09/09 Outperform NS $41.52+28.49%+27.69%+0.80
TrackHeebner 34.75 11/25/08 Outperform 1Y $49.36+8.07%+25.91%-17.84 Toggle the visibility of 60-Second Pitch and replies
TrackLeerinkSwan 92.83 06/23/08 Outperform NS $50.65+5.33%-16.24%+21.57
TrackUBS 87.99 05/09/08 Outperform NS $48.53+9.94%-19.66%+29.60
TrackWellsFargo 80.02 03/20/08 Outperform NS $51.45+3.69%-14.50%+18.19
TrackStanfordRes 85.54 10/09/07 Outperform NS $51.18+4.24%-27.81%+32.05
TrackRichAster 95.99 09/30/07 Outperform NS $49.88+6.97%-26.38%+33.34 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 90.73 09/30/07 Outperform NS $49.88+6.97%-26.38%+33.34 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 97.67 09/30/07 Outperform NS $49.88+6.97%-26.38%+33.34 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley < 20 09/30/07 Outperform NS $49.88+6.97%-26.38%+33.34 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.91 09/30/07 Outperform NS $49.88+6.97%-26.38%+33.34 Toggle the visibility of 60-Second Pitch and replies
TrackScottBleier 91.98 07/20/07 Outperform 3M $49.18+8.48%-26.47%+34.95
TrackLehmanBros 85.06 05/07/07 Outperform NS $54.49-2.09%-24.91%+22.81
TrackGaryBSmith 74.46 03/31/07 Outperform 3W $51.59+3.42%-20.18%+23.59
TrackMichaelSivy 91.90 03/20/07 Outperform 1Y $51.49+3.62%-19.59%+23.21
TrackMatrix 90.36 03/01/07 Outperform NS $49.41+7.98%-18.33%+26.30
TrackRBCCapMkts 86.33 01/25/07 Outperform NS $48.63+9.71%-20.80%+30.52
TrackAGEdwards 93.04 01/22/07 Outperform NS $48.90+9.09%-20.45%+29.55
TrackJimCramer < 20 12/06/06 Outperform 3W $44.13+20.89%-19.70%+40.59
TrackBofASec 94.61 09/05/06 Outperform NS $44.65+19.49%-13.08%+32.58
TrackRochdale 46.67 08/16/06 Outperform NS $45.04+18.44%-10.65%+29.10

Results 1 - 26 of 26  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 562ms